We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

128 hedge funds and large institutions have $1.07B invested in Dr. Reddy's Laboratories in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $1B → $1.07B (+$61M)

0.79% more ownership

Funds ownership: 75.46% → 76.25% (+0.79%)

9% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 46

4% less funds holding

Funds holding: 134 → 128 (-6)

12% less call options, than puts

Call options by funds: $548K | Put options by funds: $623K

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
128
Holders Change
-6
Holders Change %
-4.48%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
42
Reduced
46
Closed
19
Calls
$548K
Puts
$623K
Net Calls
-$75K
Net Calls Change
+$884K

Top Buyers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$36.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.09M
3
First Trust Advisors
First Trust Advisors
Illinois
+$6.86M
4
CBOA
Commonwealth Bank of Australia
Australia
+$6.86M
5
Deutsche Bank
Deutsche Bank
Germany
+$4.51M

Top Sellers

1
AQR Capital Management
AQR Capital Management
Connecticut
-$20M
2
AI
Axiom Investors
Connecticut
-$11.1M
3
CS
Credit Suisse
Switzerland
-$7M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$3.12M
5
BlackRock
BlackRock
New York
-$2.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fisher Asset Management
1
Fisher Asset Management
Washington
$236M +$1.91M +234,360 +0.8%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$146M +$36.3M +4,465,690 +35%
CBOA
3
Commonwealth Bank of Australia
Australia
$145M +$6.86M +844,090 +5%
AQR Capital Management
4
AQR Capital Management
Connecticut
$63.9M -$20M -2,463,540 -25%
Vanguard Group
5
Vanguard Group
Pennsylvania
$62.1M -$3.12M -384,175 -5%
BlackRock
6
BlackRock
New York
$54.3M -$2.83M -347,480 -5%
HSBC Holdings
7
HSBC Holdings
United Kingdom
$26.9M -$2.63M -323,930 -9%
State Street
8
State Street
Massachusetts
$26.5M +$4.32M +531,605 +20%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$24.2M +$169K +20,810 +0.7%
Northern Trust
10
Northern Trust
Illinois
$18M +$463K +56,890 +3%
Deutsche Bank
11
Deutsche Bank
Germany
$15.7M +$4.51M +554,570 +42%
First Trust Advisors
12
First Trust Advisors
Illinois
$14.1M +$6.86M +844,255 +102%
Renaissance Technologies
13
Renaissance Technologies
New York
$12M +$7.09M +872,385 +158%
Zurich Cantonal Bank
14
Zurich Cantonal Bank
Switzerland
$10.6M +$638K +78,500 +7%
JP Morgan Chase
15
JP Morgan Chase
New York
$10.2M -$2.78M -341,935 -22%
SO
16
STRS Ohio
Ohio
$9.44M – – –
DI
17
Dalton Investments
Nevada
$8.72M +$1.17M +144,000 +16%
Morgan Stanley
18
Morgan Stanley
New York
$8.56M -$2.14M -263,120 -21%
CCM
19
Causeway Capital Management
California
$7.95M -$380K -46,715 -5%
Prudential Financial
20
Prudential Financial
New Jersey
$7.77M +$2.08M +256,000 +38%
Wellington Management Group
21
Wellington Management Group
Massachusetts
$7.71M +$525K +64,580 +8%
LP
22
LMR Partners
United Kingdom
$7.48M -$2.26M -277,725 -24%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$7.13M +$2.08M +256,340 +43%
SEI Investments
24
SEI Investments
Pennsylvania
$6.95M +$41 +5 +0%
AG
25
Aperio Group
California
$6.89M +$680K +83,670 +11%
1
2 3 4 5

RDY Hedge Fund Activity: Q2 2017 in Review

128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2017, worth a combined $1.07B — up 6.1% from $1B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RDY and 13 opened new positions — a net loss of 6 holders — while 46 trimmed existing stakes and 42 added.

The largest buyer was Royal Bank of Canada, adding an estimated $36.3M. The largest seller was AQR Capital Management, cutting an estimated $20M.

  • 128 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2017, down from 134 in Q1 2017.
  • Funds reported $1.07B of Dr. Reddy's Laboratories stock for Q2 2017, up 6.1% quarter-over-quarter.
  • 13 funds opened new Dr. Reddy's Laboratories positions in Q2 2017 and 19 closed out, a net change of -6 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q2 2017 was Royal Bank of Canada, an estimated $36.3M added.
  • The largest Dr. Reddy's Laboratories seller in Q2 2017 was AQR Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2017.